Leptin Receptor Compound Heterozygosity in Humans and Animal Models

Int J Mol Sci. 2021 Apr 25;22(9):4475. doi: 10.3390/ijms22094475.

Abstract

Leptin and its receptor are essential for regulating food intake, energy expenditure, glucose homeostasis and fertility. Mutations within leptin or the leptin receptor cause early-onset obesity and hyperphagia, as described in human and animal models. The effect of both heterozygous and homozygous variants is much more investigated than compound heterozygous ones. Recently, we discovered a spontaneous compound heterozygous mutation within the leptin receptor, resulting in a considerably more obese phenotype than described for the homozygous leptin receptor deficient mice. Accordingly, we focus on compound heterozygous mutations of the leptin receptor and their effects on health, as well as possible therapy options in human and animal models in this review.

Keywords: compound heterozygous mutation; leptin receptor; mouse model.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Obesity Agents / therapeutic use
  • Bariatric Surgery
  • Disease Models, Animal
  • Heterozygote
  • Humans
  • Hyperphagia / genetics
  • Mice
  • Mutation
  • Obesity / genetics
  • Obesity / therapy*
  • Receptors, Leptin / chemistry
  • Receptors, Leptin / genetics*
  • Receptors, Leptin / metabolism*
  • alpha-MSH / analogs & derivatives
  • alpha-MSH / therapeutic use

Substances

  • Anti-Obesity Agents
  • LEPR protein, human
  • Receptors, Leptin
  • setmelanotide
  • alpha-MSH